已收盘 01-09 16:00:00 美东时间
-0.970
-0.48%
今日重点评级关注:Truist Securities:维持拜玛林制药"买入"评级,目标价从80美元升至100美元;HC Wainwright & Co.:维持Savara"买入"评级,目标价从8美元升至10美元
2025-12-24 11:17
Piper Sandler analyst John Barnidge maintains Reinsurance Gr (NYSE:RGA) with a Overweight and raises the price target from $220 to $230.
2025-12-23 20:36
Oxbridge Re Holdings Ltd (OXBR) partners with Alphaledger to bring tokenized reinsurance securities to the Solana blockchain, targeting high-yield returns of up to 42% for accredited investors.
2025-12-11 21:31
Reinsurance Group ( ($RGA) ) just unveiled an update. On December 1, 2025, Lesl...
2025-12-03 22:28
Radian Group Inc. (NYSE: RDN) announced today that its wholly owned subsidiary, Radian Guaranty Inc., has agreed to principal terms on an excess of loss (XOL) reinsurance arrangement with a panel of highly rated
2025-11-26 05:33
HAMILTON, Bermuda, Nov. 6, 2025 /PRNewswire/ -- White Mountains Insurance Group, Ltd. (NYSE: WTM) reported book value per share of $1,851 as of September 30, 2025, an increase of 3% for the ...
2025-11-06 21:00
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
2025-11-04 10:31
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据RGA Q3 2025业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **核心盈利指标:** - 运营每股收益(剔除特殊项目):6.37美元/股,创历史新高,超出预期 - 税前调整运营收入(剔除特殊项目):5.34亿美元 - 调整运营股本回报率(过去12个月,剔除特殊项目):14.2% **保费收入:** - 传统业务保费增长:年初至今按固定汇率计算增长8.5%,各地区均表现强劲 **税率表现:** - 调整运营收入有效税率:19.6%,低于预期的23%-24%区间,主要由于地区收入结构影响 **投资收益:** - 可变投资收入:较预
2025-11-03 12:04
Reinsurance Group Of America (RGA) has disclosed a new risk, in the Corporate A...
2025-11-02 13:09
Tech stocks edged higher Friday, rebounding from Thursday's 1.5% drop in the Nasdaq 100 as upbeat earnings from mega-cap giants kept the rally momentum alive.
2025-11-01 01:26